HEADER VIRAL PROTEIN 18-FEB-20 6LZ6 TITLE CRYSTAL STRUCTURE OF MERS-COV N-NTD COMPLEXED WITH LIGAND P4-3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: NUCLEOCAPSID PROTEIN,PROTEIN N; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_TAXID: 1335626; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS, NUCLEOCAPSID PROTEIN, KEYWDS 2 N-TERMINAL DOMAIN, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.H.HOU,S.M.LIN,J.N.HSU REVDAT 3 29-NOV-23 6LZ6 1 REMARK REVDAT 2 07-SEP-22 6LZ6 1 JRNL REVDAT 1 24-FEB-21 6LZ6 0 JRNL AUTH J.N.HSU,J.S.CHEN,S.M.LIN,J.Y.HONG,Y.J.CHEN,U.S.JENG,S.Y.LUO, JRNL AUTH 2 M.H.HOU JRNL TITL TARGETING THE N-TERMINUS DOMAIN OF THE CORONAVIRUS JRNL TITL 2 NUCLEOCAPSID PROTEIN INDUCES ABNORMAL OLIGOMERIZATION VIA JRNL TITL 3 ALLOSTERIC MODULATION. JRNL REF FRONT MOL BIOSCI V. 9 71499 2022 JRNL REFN ESSN 2296-889X JRNL PMID 35517857 JRNL DOI 10.3389/FMOLB.2022.871499 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.16_3549 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.26 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.430 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 19564 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1950 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.2590 - 6.3567 0.97 1279 144 0.2165 0.2439 REMARK 3 2 6.3567 - 5.0540 0.97 1229 138 0.1993 0.2382 REMARK 3 3 5.0540 - 4.4176 0.97 1258 141 0.1677 0.2103 REMARK 3 4 4.4176 - 4.0148 0.99 1270 144 0.1791 0.2145 REMARK 3 5 4.0148 - 3.7277 0.99 1284 142 0.1944 0.2415 REMARK 3 6 3.7277 - 3.5083 0.99 1250 135 0.2072 0.2587 REMARK 3 7 3.5083 - 3.3328 0.99 1304 142 0.2162 0.2723 REMARK 3 8 3.3328 - 3.1879 1.00 1239 140 0.2346 0.2855 REMARK 3 9 3.1879 - 3.0653 0.99 1310 142 0.2295 0.3078 REMARK 3 10 3.0653 - 2.9597 0.99 1222 136 0.2487 0.2786 REMARK 3 11 2.9597 - 2.8672 0.99 1289 136 0.2405 0.3331 REMARK 3 12 2.8672 - 2.7853 0.98 1268 143 0.2564 0.3441 REMARK 3 13 2.7853 - 2.7120 1.00 1251 137 0.2595 0.3263 REMARK 3 14 2.7120 - 2.6460 0.90 1161 130 0.2526 0.3116 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6LZ6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1300015747. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : TPS 05A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19587 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.646 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.30100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4J3K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN 5 MG/ML, TRIS-HCL (PH=7.5) 25 REMARK 280 MM, NACL 75 MM, MES (PH=5.5) 140 MM ,(NH4)2SO4 75 MM, PEG 3350 REMARK 280 29 %, NABR 2 MM, LIGANDS 2 MM, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 54.78850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 36 REMARK 465 SER C 36 REMARK 465 HIS C 37 REMARK 465 MET C 38 REMARK 465 ASN C 39 REMARK 465 ARG C 83 REMARK 465 LYS C 84 REMARK 465 ILE C 85 REMARK 465 ASN C 86 REMARK 465 THR C 87 REMARK 465 GLY C 88 REMARK 465 ASN C 89 REMARK 465 GLY C 90 REMARK 465 ILE C 91 REMARK 465 LYS C 92 REMARK 465 GLY C 164 REMARK 465 THR C 165 REMARK 465 SER D 36 REMARK 465 HIS D 37 REMARK 465 MET D 38 REMARK 465 ASN D 39 REMARK 465 ASP D 82 REMARK 465 ARG D 83 REMARK 465 LYS D 84 REMARK 465 ILE D 85 REMARK 465 ASN D 86 REMARK 465 THR D 87 REMARK 465 GLY D 88 REMARK 465 ASN D 89 REMARK 465 GLY D 90 REMARK 465 ILE D 91 REMARK 465 LYS D 92 REMARK 465 GLN D 93 REMARK 465 LEU D 94 REMARK 465 GLY D 119 REMARK 465 GLY D 164 REMARK 465 THR D 165 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO D 112 O HOH D 301 1.83 REMARK 500 O SER B 133 O HOH B 201 1.87 REMARK 500 O THR C 134 O HOH C 201 2.00 REMARK 500 OD2 ASP C 126 O HOH C 202 2.14 REMARK 500 O GLU D 163 O HOH D 302 2.15 REMARK 500 OG1 THR B 105 O HOH B 202 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG D 114 CA - CB - CG ANGL. DEV. = 19.2 DEGREES REMARK 500 ARG D 114 CB - CG - CD ANGL. DEV. = -24.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 89 53.72 -143.03 REMARK 500 LYS A 158 -70.38 -53.33 REMARK 500 THR B 137 -166.03 -115.31 REMARK 500 GLU D 108 42.99 -87.71 REMARK 500 PHE D 113 108.14 -45.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG D 114 ALA D 115 146.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LYS B 158 10.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EY6 D 201 DBREF1 6LZ6 A 39 165 UNP A0A2I2MQD0_9BETC DBREF2 6LZ6 A A0A2I2MQD0 39 165 DBREF1 6LZ6 B 39 165 UNP A0A2I2MQD0_9BETC DBREF2 6LZ6 B A0A2I2MQD0 39 165 DBREF1 6LZ6 C 39 165 UNP A0A2I2MQD0_9BETC DBREF2 6LZ6 C A0A2I2MQD0 39 165 DBREF1 6LZ6 D 39 165 UNP A0A2I2MQD0_9BETC DBREF2 6LZ6 D A0A2I2MQD0 39 165 SEQADV 6LZ6 SER A 36 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 HIS A 37 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 MET A 38 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 SER B 36 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 HIS B 37 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 MET B 38 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 SER C 36 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 HIS C 37 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 MET C 38 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 SER D 36 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 HIS D 37 UNP A0A2I2MQD EXPRESSION TAG SEQADV 6LZ6 MET D 38 UNP A0A2I2MQD EXPRESSION TAG SEQRES 1 A 130 SER HIS MET ASN THR VAL SER TRP TYR THR GLY LEU THR SEQRES 2 A 130 GLN HIS GLY LYS VAL PRO LEU THR PHE PRO PRO GLY GLN SEQRES 3 A 130 GLY VAL PRO LEU ASN ALA ASN SER THR PRO ALA GLN ASN SEQRES 4 A 130 ALA GLY TYR TRP ARG ARG GLN ASP ARG LYS ILE ASN THR SEQRES 5 A 130 GLY ASN GLY ILE LYS GLN LEU ALA PRO ARG TRP TYR PHE SEQRES 6 A 130 TYR TYR THR GLY THR GLY PRO GLU ALA ALA LEU PRO PHE SEQRES 7 A 130 ARG ALA VAL LYS ASP GLY ILE VAL TRP VAL HIS GLU ASP SEQRES 8 A 130 GLY ALA THR ASP ALA PRO SER THR PHE GLY THR ARG ASN SEQRES 9 A 130 PRO ASN ASN ASP SER ALA ILE VAL THR GLN PHE ALA PRO SEQRES 10 A 130 GLY THR LYS LEU PRO LYS ASN PHE HIS ILE GLU GLY THR SEQRES 1 B 130 SER HIS MET ASN THR VAL SER TRP TYR THR GLY LEU THR SEQRES 2 B 130 GLN HIS GLY LYS VAL PRO LEU THR PHE PRO PRO GLY GLN SEQRES 3 B 130 GLY VAL PRO LEU ASN ALA ASN SER THR PRO ALA GLN ASN SEQRES 4 B 130 ALA GLY TYR TRP ARG ARG GLN ASP ARG LYS ILE ASN THR SEQRES 5 B 130 GLY ASN GLY ILE LYS GLN LEU ALA PRO ARG TRP TYR PHE SEQRES 6 B 130 TYR TYR THR GLY THR GLY PRO GLU ALA ALA LEU PRO PHE SEQRES 7 B 130 ARG ALA VAL LYS ASP GLY ILE VAL TRP VAL HIS GLU ASP SEQRES 8 B 130 GLY ALA THR ASP ALA PRO SER THR PHE GLY THR ARG ASN SEQRES 9 B 130 PRO ASN ASN ASP SER ALA ILE VAL THR GLN PHE ALA PRO SEQRES 10 B 130 GLY THR LYS LEU PRO LYS ASN PHE HIS ILE GLU GLY THR SEQRES 1 C 130 SER HIS MET ASN THR VAL SER TRP TYR THR GLY LEU THR SEQRES 2 C 130 GLN HIS GLY LYS VAL PRO LEU THR PHE PRO PRO GLY GLN SEQRES 3 C 130 GLY VAL PRO LEU ASN ALA ASN SER THR PRO ALA GLN ASN SEQRES 4 C 130 ALA GLY TYR TRP ARG ARG GLN ASP ARG LYS ILE ASN THR SEQRES 5 C 130 GLY ASN GLY ILE LYS GLN LEU ALA PRO ARG TRP TYR PHE SEQRES 6 C 130 TYR TYR THR GLY THR GLY PRO GLU ALA ALA LEU PRO PHE SEQRES 7 C 130 ARG ALA VAL LYS ASP GLY ILE VAL TRP VAL HIS GLU ASP SEQRES 8 C 130 GLY ALA THR ASP ALA PRO SER THR PHE GLY THR ARG ASN SEQRES 9 C 130 PRO ASN ASN ASP SER ALA ILE VAL THR GLN PHE ALA PRO SEQRES 10 C 130 GLY THR LYS LEU PRO LYS ASN PHE HIS ILE GLU GLY THR SEQRES 1 D 130 SER HIS MET ASN THR VAL SER TRP TYR THR GLY LEU THR SEQRES 2 D 130 GLN HIS GLY LYS VAL PRO LEU THR PHE PRO PRO GLY GLN SEQRES 3 D 130 GLY VAL PRO LEU ASN ALA ASN SER THR PRO ALA GLN ASN SEQRES 4 D 130 ALA GLY TYR TRP ARG ARG GLN ASP ARG LYS ILE ASN THR SEQRES 5 D 130 GLY ASN GLY ILE LYS GLN LEU ALA PRO ARG TRP TYR PHE SEQRES 6 D 130 TYR TYR THR GLY THR GLY PRO GLU ALA ALA LEU PRO PHE SEQRES 7 D 130 ARG ALA VAL LYS ASP GLY ILE VAL TRP VAL HIS GLU ASP SEQRES 8 D 130 GLY ALA THR ASP ALA PRO SER THR PHE GLY THR ARG ASN SEQRES 9 D 130 PRO ASN ASN ASP SER ALA ILE VAL THR GLN PHE ALA PRO SEQRES 10 D 130 GLY THR LYS LEU PRO LYS ASN PHE HIS ILE GLU GLY THR HET EY6 D 201 13 HETNAM EY6 5-(2-FLUORANYLETHOXY)-1H-INDOLE FORMUL 5 EY6 C10 H10 F N O FORMUL 6 HOH *121(H2 O) HELIX 1 AA1 THR A 105 ALA A 109 5 5 HELIX 2 AA2 THR B 105 ALA B 109 5 5 HELIX 3 AA3 THR C 70 GLN C 73 5 4 HELIX 4 AA4 THR D 70 GLN D 73 5 4 SHEET 1 AA1 5 ILE A 120 HIS A 124 0 SHEET 2 AA1 5 ALA A 75 GLN A 81 -1 N TRP A 78 O VAL A 121 SHEET 3 AA1 5 ARG A 97 TYR A 102 -1 O TYR A 99 N ARG A 79 SHEET 4 AA1 5 LEU A 47 GLN A 49 -1 N LEU A 47 O TRP A 98 SHEET 5 AA1 5 PHE A 160 ILE A 162 -1 O HIS A 161 N THR A 48 SHEET 1 AA2 2 LYS A 84 ASN A 86 0 SHEET 2 AA2 2 ILE A 91 GLN A 93 -1 O LYS A 92 N ILE A 85 SHEET 1 AA3 5 ILE B 120 HIS B 124 0 SHEET 2 AA3 5 ALA B 75 GLN B 81 -1 N TRP B 78 O VAL B 121 SHEET 3 AA3 5 ARG B 97 TYR B 102 -1 O TYR B 99 N ARG B 79 SHEET 4 AA3 5 LEU B 47 GLN B 49 -1 N LEU B 47 O TRP B 98 SHEET 5 AA3 5 PHE B 160 ILE B 162 -1 O HIS B 161 N THR B 48 SHEET 1 AA4 2 LYS B 84 ASN B 86 0 SHEET 2 AA4 2 ILE B 91 GLN B 93 -1 O LYS B 92 N ILE B 85 SHEET 1 AA5 5 ILE C 120 HIS C 124 0 SHEET 2 AA5 5 ALA C 75 GLN C 81 -1 N GLY C 76 O VAL C 123 SHEET 3 AA5 5 ARG C 97 TYR C 102 -1 O TYR C 99 N ARG C 79 SHEET 4 AA5 5 LEU C 47 GLN C 49 -1 N LEU C 47 O TRP C 98 SHEET 5 AA5 5 PHE C 160 ILE C 162 -1 O HIS C 161 N THR C 48 SHEET 1 AA6 5 VAL D 121 HIS D 124 0 SHEET 2 AA6 5 ALA D 75 GLN D 81 -1 N TRP D 78 O VAL D 121 SHEET 3 AA6 5 ARG D 97 TYR D 102 -1 O TYR D 101 N TYR D 77 SHEET 4 AA6 5 LEU D 47 GLN D 49 -1 N LEU D 47 O TRP D 98 SHEET 5 AA6 5 PHE D 160 ILE D 162 -1 O HIS D 161 N THR D 48 SITE 1 AC1 7 ASN B 142 THR D 40 GLY D 104 GLY D 136 SITE 2 AC1 7 THR D 137 LEU D 156 LYS D 158 CRYST1 35.146 109.577 91.721 90.00 100.91 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028453 0.000000 0.005486 0.00000 SCALE2 0.000000 0.009126 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011103 0.00000